259 related articles for article (PubMed ID: 20480453)
1. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
Kenzel S; Hufnagel M; Berner R; Henneke P
Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
[No Abstract] [Full Text] [Related]
2. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.
Madhi SA; Adrian P; Kuwanda L; Jassat W; Jones S; Little T; Soininen A; Cutland C; Klugman KP
Vaccine; 2007 Mar; 25(13):2451-7. PubMed ID: 17023095
[TBL] [Abstract][Full Text] [Related]
4. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
[TBL] [Abstract][Full Text] [Related]
5. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.
Bolton M; Barson W
Pediatr Ann; 2010 Aug; 39(8):497-503. PubMed ID: 20704146
[No Abstract] [Full Text] [Related]
6. Pneumococcal conjugate vaccines. A review.
Galiza EP; Heath PT
Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccines for infants and children--past, present, and future.
Klein JO
Curr Clin Top Infect Dis; 2002; 22():252-65. PubMed ID: 12520657
[No Abstract] [Full Text] [Related]
8. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
9. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
10. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
12. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
13. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ; McIntosh ED; Reinert RR
Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
[TBL] [Abstract][Full Text] [Related]
14. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
Picazo JJ
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
[TBL] [Abstract][Full Text] [Related]
15. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
[No Abstract] [Full Text] [Related]
16. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
Moraga-Llop FA
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
[No Abstract] [Full Text] [Related]
17. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
Aguilar L; Giménez MJ
Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
[No Abstract] [Full Text] [Related]
18. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal conjugate vaccines: epidemiology guides clinical use.
Heininger U
Klin Padiatr; 2011 Mar; 223(2):59-60. PubMed ID: 21432762
[No Abstract] [Full Text] [Related]
20. Pneumococcal conjugated vaccine: PHiD-CV.
Dinleyici EC; Yargic ZA
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1063-74. PubMed ID: 19883326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
